Social Media and Clinical Trials: Interactions Patient-Physician Interactions, Patient-patient
Date: May 5, 2025
Duration: 60 Minutes
Time: 12 PM EST
While the use of social media as a recruitment tool is quite well known, the impact of social media goes much beyond recruitment of patients and goes into ongoing discussion between patients and investigators, investigators and sponsors, patients with other patients, and sponsor and patients. This seminar will discuss numerous ways in which social media led patient-patient, patient-investigators, investigator-sponsor, and sponsor-patient interactions and data mining can be conducted for a better, efficient and productive clinical trial. There are also concerns about maintaining trial integrity, logistical affability, and financial feasibility of using social media in clinical trials. FDA rules and industry best practices will be discussed in light of the technological challenges with using social media in clinical trials.
Areas Covered in the Session:
- Best practices for using social media for patient-investigator interactions
- Issues related to patient-patient interactions such as “Patientslikeme”
- Common ways companies are currently using social media in clinical trials
- FDA rules for using social media in clinical trials
- Crowd-sourcing, Wiki-creating, data-mining, and other social media practices for clinical trials
- Recent trends in FDA enforcement actions involving social media.
The seminar will discuss the best practices, and do’s and don’ts for using social media in clinical trials. Common issues, misconceptions, perceptions, and possible solutions will be discussed. Issues such as role of online patient communities in creating new information repositories, educational tools, information management, crisis management, public relations, and technological consistency will be discussed. Crowd-sourcing of creation, updating, selection, and management of clinical trial information will be discussed using examples from the presenter’s extensive experience in the field. The seminar will provide tips and suggestions for addressing potential issues related to individual, institutional, and regulatory obstacles to using social media in the current research landscape.
Who will benefit:
The following individuals or disciplines will benefit from attending this Webinar:
- Clinical project managers
- Clinical research associates
- Clinical coordinators
- Principle investigators
- Compliance Managers
- Regulatory Vice Presidents, Directors and Managers
- Attorneys – In-house or Outside Counsel
- Senior executives of pharmaceutical and device firms
Speaker: Mukesh Kumar
PhD, RAC | CEO, FDAMap
For more info, fill the box below. We will contact you within 24 hrs.
Webinar Fee
Prices are in US Dollars.
The registration fee includes: The live webinar & all related course materials.
Terms & Conditions to register for the Webinar
Your Registration for the workshop is subject to following terms and conditions. If you need any clarification before registering for this webinar please email us at info@fdamap.com
Payment
We accept credit card, debit card, and PayPal.
Cancellations & Substitutions:
Written cancellations through fax or email (from the person who has registered for this conference) received at least 5 business days prior to the start date of the event will receive a refund — less a $30 administration fee. No cancellations will be accepted — nor refunds issued — within 5 business days before the start date of the event. You may however, choose to substitute the webinar for which you are registered with some other webinar in the future.
On request by email or fax (before the seminar) a credit for the amount paid minus administration fees ($30) will be transferred to any future FDA Map event and a credit note will be issued. No-shows will be charged the full amount.
Webinar material will be uploaded on the website 24 hours before the scheduled date of the webinar. In case it is not available on the website due to some technical issues, we will email the material a few hours before the start of the webinar.
In the event FDA Map cancels the webinar, FDA Map will issue a full refund to all the registrants for that webinar. Some topics and speakers may be subject to change without notice.
